Trial Conduct
- CTEP Investigator's Handbook (PDF)
- NCI Guidelines for Investigators: Adverse Event Reporting Requirements for DCTD (CTEP and CIP) INDs and IDEs (PDF)
- Investigational Agent Management Policies: see the Agent Management page
- Advanced Practice Providers Writing Study Agent Orders (PDF)
- Cyberattack Response Procedures for Site Personnel (PDF)
- RECIST Guidelines (version 1.1)
Lead Organizations: Protocol Design and Conduct
Broadening Eligibility Criteria
- Broadening Eligibility Criteria Guidance (PDF) — May 2024
- Broadening Eligibility Criteria Memo (PDF) — December 2021
Slow Accrual Guidelines
- Early Phase Trial Slow Accrual Guidelines (PDF)
- Slow Accrual Guidelines for Phase 3 Trials (PDF)
- Development of Slow Accrual Guidelines (PDF)
Other LPO Topics
CTEP Program Guidelines and Policies
NCTN
- NCTN Program Guidelines (PDF) — only part 1 applies to the current program
- NCTN Data Sharing Policy (PDF)
- NCTN AYA Publications Guiding Principles (PDF) May 2024
- NCTN PMI Co-Authorship Guidelines (PDF) — February 2023
ETCTN
Memo Archive
Guidance for clinical trials affected by novel coronavirus (2020)
- CTEP/NCORP Interim Coronavirus Guidance (3/13/20)
- CTEP/NCORP Additional Coronavirus Guidance (3/23/20)
- CTEP/NCORP Guidance for COVID-19-Related Adverse Events (3/25/20)
Other Archived Memos
- AUC-Based Dosing for Carboplatin (Oct 22, 2010)